Financial News Feed

Previous Hold Today AGRX ranks #2572 as HOLD CANDIDATE. Next Hold
Today AGRX ranks #2572 as HOLD CANDIDATE.

AGRX stock Agile Therapeutics

AGRX stock
Agile Therapeutics

Agile Therapeutics Inc. (AGRX) had a good day on the market for Friday January 18 as shares jumped 14.23% to close at $0.89. About 693,843 shares traded hands on 1,366 trades for the day, compared...

Read more

As many veteran investors have already seen, market movements are extremely hard to accurately predict. Financial news outlets are always producing headlines and offering predictions for future market...

Read more

HC Wainwright reissued their buy rating on shares of Agile Therapeutics (NASDAQ:AGRX) in a research note issued to investors on Friday morning. The firm currently has a $4.00 price objective on the sp...

Read more

Sentiment for Algorx Pharmaceuticals Inc (NASDAQ:AGRX) Algorx Pharmaceuticals Inc (NASDAQ:AGRX) institutional sentiment increased to 0.75 in 2018 Q3. Its up 0.05, from 0.7 in 2018Q2. The ratio is posi...

Read more

Sentiment for AGILE THERAPEUTICS INC (NASDAQ:AGRX) AGILE THERAPEUTICS INC (NASDAQ:AGRX) institutional sentiment increased to 0.75 in Q3 2018. Its up 0.05, from 0.7 in 2018Q2. The ratio is positive, as...

Read more

HC Wainwright reaffirmed their buy rating on shares of Agile Therapeutics (NASDAQ:AGRX) in a report released on Friday morning. HC Wainwright currently has a $4.00 target price on the specialty pharma...

Read more

HC Wainwright reiterated their buy rating on shares of Agile Therapeutics (NASDAQ:AGRX) in a report published on Friday morning. HC Wainwright currently has a $4.00 target price on the specialty pharm...

Read more

Moving average convergence divergence (MACD) is a trend-following momentum indicator that illustrates the relationship between two moving averages. MACD is calculated by subtracting the 26-day exponen...

Read more

According to the latest Filings, Agile Therapeutics, Inc. (NASDAQ:AGRX) have decreased their position in the stock by -43.10% over the past 6 months. Insiders now own 1.15% of total outstanding shares...

Read more

Shares of Agile Therap (AGRX) have been trending up over the past quarter, revealing solid bullish momentum for the equity, as they ran 120.62 over the past 13 weeks. Looking more nearterm, the stock ...

Read more

Agile Therapeutics (Nasdaq:AGRX), a women’s healthcare company, announced that on January 9, 2019 it received final meeting minutes from its December 11, 2018 meeting with the U.S. Food and Drug Adm...

Read more

Even though the stock market can seem erratic and unpredictable, investors may be able to take some steps to help combat the chaos. One thing that investors have the ability to do is create an overall...

Read more

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Agile Therapeutics (AGRX), NovaBay Pharma ... The post Analysts Are Bullish on These Healthcare Stocks:...

Read more

Analyst Ratings For Agile Therapeutics Inc (NASDAQ:AGRX) Today, HC Wainwright reiterated its Buy rating on Agile Therapeutics Inc (NASDAQ:AGRX). There are 4 Buy Ratings, no Strong Buy Ratings, no Sell...

Read more

Discussions with FDA on Design of Comparative Wear Study of Twirla ® and Xulane ® Completed Cash Expected to Enable Company to Fund Operations into Second Quarter of 2019 PRINCETON, N.J., Jan. 10, 2...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank